ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Minnesota » Neurology

Top Neurology Prescribers in Minnesota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAYME BORK

Neurology

12,674

$1.39M

599
108 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$110
Average prescription price

Avg: $233

SUDHIR REDDY MD

Neurology

5,702

$852K

367
81 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 21%

$149
Average prescription price

Avg: $233

JONATHAN CALKWOOD M.D.

Neurology

5,688

$6.04M

338
104 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 21%

$1062
Average prescription price

Avg: $233

DEANNA DICKENS MD

Neurology

5,408

$970K

265
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$179
Average prescription price

Avg: $233

DAVID GISH MD

Neurology

5,307

$420K

393
290 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 21%

$79
Average prescription price

Avg: $233

PATRICIA PENOVICH MD

Neurology

5,223

$1.51M

210
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 21%

$289
Average prescription price

Avg: $233

MARTHA NANCE

Neurology

4,390

$1.62M

502
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 21%

$369
Average prescription price

Avg: $233

RICHARD GOLDEN M.D.

Neurology

3,591

$1.44M

353
263 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 21%

$401
Average prescription price

Avg: $233

CHARLES ORMISTON M.D.

Neurology

3,558

$608K

362
232 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$171
Average prescription price

Avg: $233

ILO LEPPIK M.D.

Neurology

3,492

$821K

171
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$235
Average prescription price

Avg: $233

PAUL SCHANFIELD M.D.

Neurology

3,256

$723K

353
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$222
Average prescription price

Avg: $233

WOLCOTT HOLT

Neurology

3,200

$686K

292
116 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$214
Average prescription price

Avg: $233

MASOOD GHAZALI M.B., B.S.

Neurology

3,169

$730K

512
349 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

2%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$230
Average prescription price

Avg: $233

STEVEN STEIN M.D.

Neurology

3,160

$746K

382
300 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$236
Average prescription price

Avg: $233

JULIE HANNA M.D.

Neurology

3,054

$501K

169
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 21%

$164
Average prescription price

Avg: $233

NADEEM IQBAL M.D.

Neurology

2,995

$528K

374
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$176
Average prescription price

Avg: $233

PAUL TUITE MD

Neurology

2,995

$728K

333
244 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 21%

$243
Average prescription price

Avg: $233

FELIX ZWIEBEL M.D.

Neurology

2,934

$556K

352
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$190
Average prescription price

Avg: $233

DEBORAH OSGOOD PA-C

Neurology

2,922

$551K

477
238 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 21%

$189
Average prescription price

Avg: $233

KATHLEEN RIEKE MD

Neurology

2,832

$489K

273
155 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$173
Average prescription price

Avg: $233

THOMAS JACQUES M.D.

Neurology

2,775

$543K

340
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 21%

$196
Average prescription price

Avg: $233

SUSAN MINETTE D.O.

Neurology

2,731

$528K

283
203 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 21%

$193
Average prescription price

Avg: $233

ROBERT JACOBY M.D.

Neurology

2,707

$728K

275
123 are 65+

27%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$269
Average prescription price

Avg: $233

SOTIRIOS PARASHOS M.D., PH.D.

Neurology

2,701

$570K

308
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 21%

$211
Average prescription price

Avg: $233

MERLIN NELSON MD

Neurology

2,629

$597K

347
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 21%

$227
Average prescription price

Avg: $233

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank